COMMUNIQUÉS West-GlobeNewswire

-
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
20/08/2019 -
Arbutus Biopharma Appoints Andrew Cheng, M.D., Ph.D., to its Board of Directors
20/08/2019 -
MRI Interventions’ Achieves 3,000th ClearPoint® Neuro Navigation Procedure
20/08/2019 -
HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/08/2019 -
Fluidigm to Participate in Upcoming Health Care Investor Conferences
20/08/2019 -
NEO Tech and Podimetrics Announce New Manufacturing Partnership in Westborough
20/08/2019 -
DrugCendR Inc. Announces the Appointment of Dr. Daniel Von Hoff as Clinical Advisor
20/08/2019 -
Driven Deliveries 2019 Shareholder Letter
20/08/2019 -
Waterloo Wellington signs on to Roots of Hope national suicide prevention project
20/08/2019 -
Waterloo Wellington se joint au projet national de prévention du suicide Enraciner l’espoir
20/08/2019 -
Capital Increase in Genmab as a Result of Employee Warrant Exercise
20/08/2019 -
UPDATE -- VitalHub Anticipates Releasing Second Quarter Results
20/08/2019 -
Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor
20/08/2019 -
Inventiva enregistre un nouveau brevet aux États-Unis renforçant la protection de son candidat médicament phare lanifibranor
20/08/2019 -
Genkyotex Extends Conversion Period for Outstanding €1.6 Million Convertible Debt by 12 Months
20/08/2019 -
Genkyotex prolonge de 12 mois la période de conversion de ses obligations convertibles en actions en circulation pour un montant nominal total de 1,6 millions d’euros
20/08/2019 -
VitalHub Anticipates Releasing Second Quarter Results
20/08/2019 -
PRA Health Sciences annonce une alliance stratégique entre Symphony Health et Close-Up International
20/08/2019 -
PCI Biotech: Invitation to second quarter and first half 2019 results presentation
20/08/2019
Pages